281 related articles for article (PubMed ID: 17272325)
21. Phenotype variability in patients carrying KCNJ2 mutations.
Kimura H; Zhou J; Kawamura M; Itoh H; Mizusawa Y; Ding WG; Wu J; Ohno S; Makiyama T; Miyamoto A; Naiki N; Wang Q; Xie Y; Suzuki T; Tateno S; Nakamura Y; Zang WJ; Ito M; Matsuura H; Horie M
Circ Cardiovasc Genet; 2012 Jun; 5(3):344-53. PubMed ID: 22589293
[TBL] [Abstract][Full Text] [Related]
22. Electrocardiogram in Andersen-Tawil syndrome. New electrocardiographic criteria for diagnosis of type-1 Andersen-Tawil syndrome.
Kukla P; Biernacka EK; Baranchuk A; Jastrzebski M; Jagodzinska M
Curr Cardiol Rev; 2014 Aug; 10(3):222-8. PubMed ID: 24827800
[TBL] [Abstract][Full Text] [Related]
23. Oral verapamil effectively suppressed complex ventricular arrhythmias and unmasked U waves in a patient with Andersen-Tawil syndrome.
Erdogan O; Aksoy A; Turgut N; Durusoy E; Samsa M; Altun A
J Electrocardiol; 2008; 41(4):325-8. PubMed ID: 18353348
[TBL] [Abstract][Full Text] [Related]
24. A novel KCNJ2 nonsense mutation, S369X, impedes trafficking and causes a limited form of Andersen-Tawil syndrome.
Doi T; Makiyama T; Morimoto T; Haruna Y; Tsuji K; Ohno S; Akao M; Takahashi Y; Kimura T; Horie M
Circ Cardiovasc Genet; 2011 Jun; 4(3):253-60. PubMed ID: 21493816
[TBL] [Abstract][Full Text] [Related]
25. Andersen cardiodysrhythmic periodic paralysis with KCNJ2 mutations: a novel mutation in the pore selectivity filter residue.
Lim BC; Kim GB; Bae EJ; Noh CI; Hwang H; Kim KJ; Hwang YS; Ko TS; Chae JH
J Child Neurol; 2010 Apr; 25(4):490-3. PubMed ID: 20382953
[TBL] [Abstract][Full Text] [Related]
26. Flecainide for recurrent malignant ventricular arrhythmias in two siblings with Andersen-Tawil syndrome.
Bökenkamp R; Wilde AA; Schalij MJ; Blom NA
Heart Rhythm; 2007 Apr; 4(4):508-11. PubMed ID: 17399642
[No Abstract] [Full Text] [Related]
27. A Kir3.4 mutation causes Andersen-Tawil syndrome by an inhibitory effect on Kir2.1.
Kokunai Y; Nakata T; Furuta M; Sakata S; Kimura H; Aiba T; Yoshinaga M; Osaki Y; Nakamori M; Itoh H; Sato T; Kubota T; Kadota K; Shindo K; Mochizuki H; Shimizu W; Horie M; Okamura Y; Ohno K; Takahashi MP
Neurology; 2014 Mar; 82(12):1058-64. PubMed ID: 24574546
[TBL] [Abstract][Full Text] [Related]
28. Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1.
Mazzanti A; Guz D; Trancuccio A; Pagan E; Kukavica D; Chargeishvili T; Olivetti N; Biernacka EK; Sacilotto L; Sarquella-Brugada G; Campuzano O; Nof E; Anastasakis A; Sansone VA; Jimenez-Jaimez J; Cruz F; Sánchez-Quiñones J; Hernandez-Afonso J; Fuentes ME; Średniawa B; Garoufi A; Andršová I; Izquierdo M; Marinov R; Danon A; Expósito-García V; Garcia-Fernandez A; Muñoz-Esparza C; Ortíz M; Zienciuk-Krajka A; Tavazzani E; Monteforte N; Bloise R; Marino M; Memmi M; Napolitano C; Zorio E; Monserrat L; Bagnardi V; Priori SG
J Am Coll Cardiol; 2020 Apr; 75(15):1772-1784. PubMed ID: 32299589
[TBL] [Abstract][Full Text] [Related]
29. Mosaic KCNJ2 mutation in Andersen-Tawil syndrome: targeted deep sequencing is useful for the detection of mosaicism.
Hasegawa K; Ohno S; Kimura H; Itoh H; Makiyama T; Yoshida Y; Horie M
Clin Genet; 2015 Mar; 87(3):279-83. PubMed ID: 24635491
[TBL] [Abstract][Full Text] [Related]
30. Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype.
Zhang L; Benson DW; Tristani-Firouzi M; Ptacek LJ; Tawil R; Schwartz PJ; George AL; Horie M; Andelfinger G; Snow GL; Fu YH; Ackerman MJ; Vincent GM
Circulation; 2005 May; 111(21):2720-6. PubMed ID: 15911703
[TBL] [Abstract][Full Text] [Related]
31. Non dominant-negative KCNJ2 gene mutations leading to Andersen-Tawil syndrome with an isolated cardiac phenotype.
Limberg MM; Zumhagen S; Netter MF; Coffey AJ; Grace A; Rogers J; Böckelmann D; Rinné S; Stallmeyer B; Decher N; Schulze-Bahr E
Basic Res Cardiol; 2013 May; 108(3):353. PubMed ID: 23644778
[TBL] [Abstract][Full Text] [Related]
32. Identification and functional characterisation of a novel KCNJ2 mutation, Val302del, causing Andersen-Tawil syndrome.
Ördög B; Hategan L; Kovács M; Seprényi G; Kohajda Z; Nagy I; Hegedűs Z; Környei L; Jost N; Katona M; Szekeres M; Forster T; Papp JG; Varró A; Sepp R
Can J Physiol Pharmacol; 2015 Jul; 93(7):569-75. PubMed ID: 26103554
[TBL] [Abstract][Full Text] [Related]
33. Kir 2.1 channelopathies: the Andersen-Tawil syndrome.
Tristani-Firouzi M; Etheridge SP
Pflugers Arch; 2010 Jul; 460(2):289-94. PubMed ID: 20306271
[TBL] [Abstract][Full Text] [Related]
34. [A new type of periodic paralysis: Andersen-Tawil syndrome].
Pouget J
Bull Acad Natl Med; 2008 Nov; 192(8):1551-6; discussion 1556-7. PubMed ID: 19445372
[TBL] [Abstract][Full Text] [Related]
35. Andersen-Tawil syndrome: new potassium channel mutations and possible phenotypic variation.
Davies NP; Imbrici P; Fialho D; Herd C; Bilsland LG; Weber A; Mueller R; Hilton-Jones D; Ealing J; Boothman BR; Giunti P; Parsons LM; Thomas M; Manzur AY; Jurkat-Rott K; Lehmann-Horn F; Chinnery PF; Rose M; Kullmann DM; Hanna MG
Neurology; 2005 Oct; 65(7):1083-9. PubMed ID: 16217063
[TBL] [Abstract][Full Text] [Related]
36. Reduction of complex ventricular ectopy and improvement in exercise capacity with flecainide therapy in Andersen-Tawil syndrome.
Fox DJ; Klein GJ; Hahn A; Skanes AC; Gula LJ; Yee RK; Subbiah RN; Krahn AD
Europace; 2008 Aug; 10(8):1006-8. PubMed ID: 18621769
[TBL] [Abstract][Full Text] [Related]
37. Identification of the KCNJ2 Mutation in a Korean Family with Andersen-Tawil Syndrome and Developmental Delay.
Kim NR; Jang JH; Jeon GW; Cho EH; Sin JB
Ann Clin Lab Sci; 2016; 46(1):110-3. PubMed ID: 26927354
[TBL] [Abstract][Full Text] [Related]
38. Corticosteroid-exacerbated symptoms in an Andersen's syndrome kindred.
Bendahhou S; Fournier E; Gallet S; Ménard D; Larroque MM; Barhanin J
Hum Mol Genet; 2007 Apr; 16(8):900-6. PubMed ID: 17324964
[TBL] [Abstract][Full Text] [Related]
39. Electrophysiological mechanisms of ventricular arrhythmias in relation to Andersen-Tawil syndrome under conditions of reduced IK1: a simulation study.
Sung RJ; Wu SN; Wu JS; Chang HD; Luo CH
Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2597-605. PubMed ID: 16877549
[TBL] [Abstract][Full Text] [Related]
40. Imipramine for incessant ventricular arrhythmias in 2 unrelated patients with Andersen-Tawil syndrome.
Bigelow AM; Khalifa MM; Clark JM
Heart Rhythm; 2015 Jul; 12(7):1654-7. PubMed ID: 25814423
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
